{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:08:34Z","timestamp":1790381314566,"version":"4.1.0"},"reference-count":77,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T00:00:00Z","timestamp":1512950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["204809\/Z\/16\/Z"],"award-info":[{"award-number":["204809\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"European Union Seventh Framework Programme","doi-asserted-by":"publisher","award":["304948\u2014NanoMal"],"award-info":[{"award-number":["304948\u2014NanoMal"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"DOI":"10.1093\/jac\/dkx431","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T16:41:24Z","timestamp":1509640884000},"page":"581-595","source":"Crossref","is-referenced-by-count":50,"title":["Clinical implications of Plasmodium resistance to atovaquone\/proguanil: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"73","author":[{"given":"Henry M","family":"Staines","sequence":"first","affiliation":[{"name":"Centre for Diagnostics and Antimicrobial Resistance, Institute for Infection & Immunity, St George\u2019s University of London, London, UK"},{"name":"Institute for Infection & Immunity, St George's University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah","family":"Burrow","sequence":"additional","affiliation":[{"name":"Institute for Infection & Immunity, St George's University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrix Huei-Yi","family":"Teo","sequence":"additional","affiliation":[{"name":"Institute for Infection & Immunity, St George's University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Chis Ster","sequence":"additional","affiliation":[{"name":"Institute for Infection & Immunity, St George's University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G","family":"Kremsner","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Tropenmedizin Universit\u00e4tsklinikum T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Centre de Recherches M\u00e9dicales de Lambar\u00e9n\u00e9, Lambar\u00e9n\u00e9, Gabon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Krishna","sequence":"additional","affiliation":[{"name":"Centre for Diagnostics and Antimicrobial Resistance, Institute for Infection & Immunity, St George\u2019s University of London, London, UK"},{"name":"Institute for Infection & Immunity, St George's University of London, London, UK"},{"name":"Institut f\u00fcr Tropenmedizin Universit\u00e4tsklinikum T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Centre de Recherches M\u00e9dicales de Lambar\u00e9n\u00e9, Lambar\u00e9n\u00e9, Gabon"},{"name":"St George\u2019s University Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,12,11]]},"reference":[{"key":"key\n\t\t\t\t20180328140435_dkx431-B1","author":"WHO","year":"2015"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B2","author":"WHO","year":"2016"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B3","doi-asserted-by":"crossref","first-page":"313.","DOI":"10.1016\/j.pt.2013.04.001","article-title":"Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy","volume":"29","author":"Krishna","year":"2013","journal-title":"Trends Parasitol"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B4","author":"WHO","year":"2012"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B5","author":"PHE","year":"2017"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B6","doi-asserted-by":"crossref","first-page":"260106.","DOI":"10.1155\/2015\/260106","article-title":"Rational risk-benefit decision-making in the setting of military mefloquine policy","volume":"2015","author":"Nevin","year":"2015","journal-title":"J Parasitol Res"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cbpa.2010.05.005","article-title":"Inhibiting Plasmodium cytochrome bc1: a complex issue","volume":"14","author":"Barton","year":"2010","journal-title":"Curr Opin Chem Biol"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B8","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1128\/AAC.43.6.1334","article-title":"A mechanism for the synergistic antimalarial action of atovaquone and proguanil","volume":"43","author":"Srivastava","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B9","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1073\/pnas.87.8.3014","article-title":"Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance","volume":"87","author":"Foote","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B10","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/bmj.326.7390.628","article-title":"Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports","volume":"326","author":"F\u00e4rnert","year":"2003","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-1-1","article-title":"Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria","volume":"1","author":"Fivelman","year":"2002","journal-title":"Malar J"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B12","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1016\/j.micinf.2006.07.011","article-title":"Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations","volume":"8","author":"Musset","year":"2006","journal-title":"Microbes Infect"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1126\/science.aad9279","article-title":"Parasites resistant to the antimalarial atovaquone fail to transmit by mosquitoes","volume":"352","author":"Goodman","year":"2016","journal-title":"Science"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B14","first-page":"317","article-title":"Proguanil disposition and toxicity in malaria patients from Vanuatu with high frequencies of CYP2C19 mutations","volume":"9","author":"Kaneko","year":"1999","journal-title":"Pharmacogenetics"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B15","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B16","first-page":"CD004529","article-title":"Atovaquone-proguanil for treating uncomplicated malaria","volume":"4","author":"Osei-Akoto","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4269\/ajtmh.2012.11-0192","article-title":"Randomized, prospective, three-arm study to confirm the auditory safety and efficacy of artemether-lumefantrine in Colombian patients with uncomplicated Plasmodium falciparum malaria","volume":"86","author":"Carrasquilla","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B18","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1128\/AAC.01677-08","article-title":"Dynamics of malaria drug resistance patterns in the Amazon basin region following changes in Peruvian national treatment policy for uncomplicated malaria","volume":"53","author":"Bacon","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B19","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/1475-2875-10-304","article-title":"A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon","volume":"10","author":"Frank","year":"2011","journal-title":"Malar J"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00436-006-0287-8","article-title":"No variation in the prevalence of point mutations in the Pfcrt and Pfmdr1 genes in isolates from Gabonese patients with uncomplicated or severe Plasmodium falciparum malaria","volume":"100","author":"Mayengue","year":"2007","journal-title":"Parasitol Res"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B21","doi-asserted-by":"crossref","first-page":"986","DOI":"10.4269\/ajtmh.2006.74.986","article-title":"Folic acid treatment of Zambian children with moderate to severe malaria anemia","volume":"74","author":"Mulenga","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B22","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1128\/AAC.03956-14","article-title":"Molecular characterization of the cytochrome b gene and in vitro atovaquone susceptibility of Plasmodium falciparum isolates from Kenya","volume":"59","author":"Ingasia","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00508-011-0044-6","article-title":"Sensitivity of Plasmodium vivax to chloroquine, mefloquine, artemisinin and atovaquone in north-western Thailand","volume":"123","author":"Treiber","year":"2011","journal-title":"Wien Klin Wochenschr"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1006\/expr.1995.1049","article-title":"Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro","volume":"80","author":"Canfield","year":"1995","journal-title":"Exp Parasitol"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B25","author":"House of Commons Defence Committee","year":"2016"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B26","doi-asserted-by":"crossref","first-page":"e18162","DOI":"10.1371\/journal.pone.0018162","article-title":"Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery","volume":"6","author":"Dembele","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/1475-2875-7-240","article-title":"Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil","volume":"7","author":"Sutherland","year":"2008","journal-title":"Malar J"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B28","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/AAC.46.8.2435-2441.2002","article-title":"Mutations in cytochrome b resulting in atovaquone resistance are associated with loss of fitness in Plasmodium falciparum","volume":"46","author":"Peters","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B29","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1128\/AAC.02550-13","article-title":"Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reports","volume":"58","author":"Cottrell","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B30","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00006454-199905000-00011","article-title":"Combination atovaquone and proguanil hydrochloride vs. halofantrine for treatment of acute Plasmodium falciparum malaria in children","volume":"18","author":"Anabwani","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B31","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1086\/379014","article-title":"Atovaquone and proguanil versus amodiaquine for the treatment of Plasmodium falciparum malaria in African infants and young children","volume":"37","author":"Borrmann","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B32","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4269\/ajtmh.2000.63.274","article-title":"Atovaquone plus proguanil versus halofantrine for the treatment of imported acute uncomplicated Plasmodium falciparum malaria in non-immune adults: a randomized comparative trial","volume":"63","author":"Bouchaud","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B33","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1086\/314770","article-title":"Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines","volume":"179","author":"Bustos","year":"1999","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B34","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1086\/516497","article-title":"Atovaquone and proguanil for the treatment of malaria in Brazil","volume":"175","author":"de Alencar","year":"1997","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B35","doi-asserted-by":"crossref","first-page":"179.","DOI":"10.1186\/1475-2875-7-179","article-title":"Ototoxicity of artemether\/lumefantrine in the treatment of falciparum malaria: a randomized trial","volume":"7","author":"G\u00fcrkov","year":"2008","journal-title":"Malar J"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-3156.2003.01180.x","article-title":"CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam","volume":"9","author":"Giao","year":"2004","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1590\/S1413-86702001000200004","article-title":"Atovaquone and proguani hydrochloride compared with chloroquine or pyrimethamine\/sulfodaxine for treatment of acute Plasmodium falciparum malaria in Peru","volume":"5","author":"Llanos-Cuentas","year":"2001","journal-title":"Braz J Infect Dis"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B38","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4269\/ajtmh.1999.60.526","article-title":"Efficacy and safety of atovaquone\/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand","volume":"60","author":"Looareesuwan","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B39","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0149-2918(99)80006-X","article-title":"Atovaquone and proguanil versus pyrimethamine\/sulfadoxine for the treatment of acute falciparum malaria in Zambia","volume":"21","author":"Mulenga","year":"1999","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B40","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(96)90671-6","article-title":"Atovaquone and proguanil for Plasmodium falciparum malaria","volume":"347","author":"Radloff","year":"1996","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B41","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/infdis\/jiu341","article-title":"Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children","volume":"210","author":"Tahar","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B42","first-page":"245","article-title":"Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris","volume":"15","author":"Blonde","year":"2008","journal-title":"Arch Pediatr"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B43","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1086\/605431","article-title":"Use of peroxisome proliferator-activated receptor \u03b3 agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial","volume":"49","author":"Boggild","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1475-2875-11-212","article-title":"Therapy of uncomplicated falciparum malaria in Europe: MALTHER\u2014a prospective observational multicentre study","volume":"11","author":"Bouchaud","year":"2012","journal-title":"Malar J"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B45","doi-asserted-by":"crossref","first-page":"598","DOI":"10.5694\/j.1326-5377.2006.tb00723.x","article-title":"Outpatient treatment of malaria in recently arrived African migrants","volume":"185","author":"Chih","year":"2006","journal-title":"Med J Aust"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B46","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4269\/ajtmh.1997.56.315","article-title":"In vitro response of Plasmodium falciparum to atovaquone and correlation with other antimalarials: comparison between African and Asian strains","volume":"56","author":"Gay","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4269\/ajtmh.14-0249","article-title":"Artemether-lumefantrine compared to atovaquone-proguanil as a treatment for uncomplicated Plasmodium falciparum malaria in travelers","volume":"92","author":"Grynberg","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B48","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4269\/ajtmh.2007.76.655","article-title":"Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand","volume":"76","author":"Krudsood","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B49","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1086\/343750","article-title":"Atovaquone\/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity","volume":"35","author":"Lacy","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B50","first-page":"229","article-title":"Experience with the combination atovaquone-proguanil in the treatment of uncomplicated Plasmodium falciparum malaria\u2014report of 112 cases","volume":"62","author":"Malvy","year":"2002","journal-title":"Med Trop (Mars)"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B51","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00228-005-0969-7","article-title":"The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women","volume":"61","author":"Na-Bangchang","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B52","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0035-9203(98)90749-0","article-title":"Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria","volume":"92","author":"Sabchareon","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B53","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.actatropica.2012.10.002","article-title":"Field evaluation of rapid diagnostic tests for malaria in Yaounde, Cameroon","volume":"125","author":"Tahar","year":"2013","journal-title":"Acta Trop"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B54","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2310\/7060.2004.19005","article-title":"Atovaquone-proguanil (malarone): an effective treatment for uncomplicated Plasmodium falciparum malaria in travelers from Denmark","volume":"11","author":"Thybo","year":"2004","journal-title":"J Travel Med"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4269\/ajtmh.1996.54.62","article-title":"Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand","volume":"54","author":"Looareesuwan","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B56","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0035-9203(96)90435-6","article-title":"Atovaquone plus proguanil is an effective treatment for Plasmodium ovale and P. malariae malaria","volume":"90","author":"Radloff","year":"1996","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B57","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4269\/ajtmh.2003.69.179","article-title":"Molecular epidemiology of malaria in Cameroon. XVII. Baseline monitoring of atovaquone-resistant Plasmodium falciparum by in vitro drug assays and cytochrome b gene sequence analysis","volume":"69","author":"Basco","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B58","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3201\/eid1402.070945","article-title":"Plasmodium falciparum malaria and atovaquone-proguanil treatment failure","volume":"14","author":"Durand","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B59","doi-asserted-by":"crossref","first-page":"23.","DOI":"10.1186\/1475-2875-7-23","article-title":"In vitro atovaquone\/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand","volume":"7","author":"Khositnithikul","year":"2008","journal-title":"Malar J"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B60","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1128\/AAC.01532-06","article-title":"First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America","volume":"51","author":"Legrand","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B61","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00508-006-0685-z","article-title":"Pharmacodynamic interaction between atovaquone and other antimalarial compounds against Plasmodium falciparum in vitro","volume":"118","author":"L\u00fctgendorf","year":"2006","journal-title":"Wien Klin Wochenschr"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B62","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/jac\/dki420","article-title":"Apparent absence of atovaquone\/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers","volume":"57","author":"Musset","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B63","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1128\/AAC.00282-08","article-title":"First case of emergence of atovaquone-proguanil resistance in Plasmodium falciparum during treatment in a traveler in Comoros","volume":"52","author":"Savini","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B64","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1086\/344901","article-title":"Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil","volume":"35","author":"van Vugt","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B65","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4269\/ajtmh.2005.73.188","article-title":"Occult Plasmodium vivax infection diagnosed by a polymerase chain reaction-based detection system: a case report","volume":"73","author":"Blossom","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B66","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.lpm.2011.03.009","article-title":"Atovaquone-proguanil treatment failure in Plasmodium falciparum","volume":"40","author":"Contentin","year":"2011","journal-title":"Presse Med"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B67","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/00365540310016862","article-title":"Atovaquone\/proguanil resistance in Africa: a case report","volume":"35","author":"David","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B68","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.medmal.2010.07.007","article-title":"Post-malaria neurological syndrome complicating a relapse of Plasmodium falciparum malaria after atovaquone-proguanil treatment","volume":"41","author":"Forestier","year":"2011","journal-title":"Med Mal Infect"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B69","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00436-006-0317-6","article-title":"Cerebral malaria in spite of peripheral parasite clearance in a patient treated with atovaquone\/proguanil","volume":"100","author":"Koch","year":"2007","journal-title":"Parasitol Res"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B70","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4269\/ajtmh.2005.72.407","article-title":"Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa","volume":"72","author":"Kuhn","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B71","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00436-007-0804-4","article-title":"Plasmodium malariae infection in spite of previous anti-malarial medication","volume":"102","author":"M\u00fcller-St\u00f6ver","year":"2008","journal-title":"Parasitol Res"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B72","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.tmaid.2007.02.003","article-title":"Relapsing malaria infection in an adolescent following travel to Mozambique","volume":"5","author":"Oswald","year":"2007","journal-title":"Travel Med Infect Dis"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B73","first-page":"e10","article-title":"Severe atovaquone-resistant Plasmodium falciparum malaria in a Canadian traveller returned from the Indian subcontinent","volume":"3","author":"Perry","year":"2009","journal-title":"Open Med"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B74","doi-asserted-by":"crossref","first-page":"ofu059","DOI":"10.1093\/ofid\/ofu059","article-title":"Novel mutation in cytochrome b of Plasmodium falciparum in one of two atovaquone-proguanil treatment failures in travelers returning from same site in Nigeria","volume":"1","author":"Plucinski","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B75","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/INF.0b013e318167918d","article-title":"Atovaquone-proguanil resistance in imported falciparum malaria in a young child","volume":"27","author":"Rose","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B76","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1086\/375599","article-title":"Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa","volume":"37","author":"Schwartz","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328140435_dkx431-B77","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1475-2875-3-14","article-title":"Malarone treatment failure not associated with previously described mutations in the cytochrome b gene","volume":"3","author":"Wichmann","year":"2004","journal-title":"Malar J"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/3\/581\/24332348\/dkx431.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T10:04:48Z","timestamp":1570269888000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/3\/581\/4693708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,11]]},"references-count":77,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,12,11]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx431","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2017,12,11]]}}}